Low Dose Rate (LDR) - Breast Cancer Brachytherapy Market
The global low dose rate (ldr) breast cancer brachytherapy market size was valued at US$ 19.7 million in 2018 and is estimated to grow at a compound annual growth rate (CAGR) of 5.4% from 2018 to 2027.
Low dose rate (ldr) - Breast cancer brachytherapy market highlights
- The global low dose rate (ldr) segment generated a revenue of USD 19.7 million in 2018 and is expected to reach USD 31.6 million by 2027.
- The market is expected to grow at a CAGR (2019 - 2027) of 5.6% by 2027.
- In terms of region, North America was the largest revenue generating market in 2018.
- Country-wise, India is expected to register the highest CAGR from 2019 to 2027.
Market summary
| Market revenue in 2018 | USD 19.7 million |
| Market revenue in 2027 | USD 31.6 million |
| Growth rate | 5.6% (CAGR from 2019 to 2027) |
| Historical data covered | 2015 - 2017 |
| Base year for estimation | 2018 |
| Forecast period covered | 2019 - 2027 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Brachytherapy Market Scope
Breast cancer brachytherapy market segmentation & scope
Breast Cancer Brachytherapy Market
- HTML
- PPT
- -
Everything on Breast Cancer Brachytherapy Market in one document: edited and divided into chapters, including detailed references.
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
